Cytokinetics (CYTK) PT Raised to $54 at JPMorgan following bullish physician survey
Tweet Send to a Friend
(Updated - June 22, 2023 9:02 AM EDT)
JPMorgan analyst Tessa Romero raised the price target on Cytokinetics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Tessa Romero raised the price target on Cytokinetics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
